Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL

Maturitas

Volumn 29, Issue 2, 1998, Pages 155-161

  Heikkinen, Anna Mari ^a   Niskanen, Leo ^b   Ylä Herttuala, Seppo ^c   Luoma, Jukka ^c   Tuppurainen, Marjo T ^a   Komulainen, Marja ^a   Saarikoski, Seppo ^a  

^a PO Box 1777 ^*  (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cholesterol; Cyproterone acetate; Estradiol valerate; Menopause; Oxidized lipoprotein cholesterol

Indexed keywords

AUTOANTIBODY; CALCIUM LACTATE; CALSOR; CHOLESTEROL; COLECALCIFEROL DERIVATIVE; CYPROTERONE ACETATE; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; ESTRADIOL VALERATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG MIXTURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

AUTOANTIBODIES; CALCIUM COMPOUNDS; CHOLECALCIFEROL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LACTATES; LIPOPROTEINS, LDL; MIDDLE AGED; OXIDATION-REDUCTION; POSTMENOPAUSE; PROSPECTIVE STUDIES;

EID: 0032478944     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(98)00002-4     Document Type: Article

References (28)

1. Barret-Connor E., Bush T.L. Estrogen and coronary heart disease in women. J Am Med Assoc. 265:1991;1861-1867.
2. Nabulsi A.A., Folsom A.R., White A. et al. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. New Engl J Med. 328:1993;1069-1075.
3. Gangar K.F., Reid B.A., Crook D., Hillard T.C., Whitehead M.I. Oestrogens and atherosclerotic vascular disease-local vascular factors. Bailliére's Clin Endocrinol Metab. 17:1993;47-93.
4. Sugioka K., Shimosegawa Y., Nakano M. Estrogens as natural antioxidant of membrane phospholipid peroxidation. FEBS Lett. 219:1987;37-39.
5. Salonen J.T., Ylä-Herttuala S., Yamamoto R. et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
6. Puurunen M., Mänttäri M., Manninen V. et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med. 154:1994;2605-2609.
7. Bui M.N., Sack M.N., Moutsatsos G. et al. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Am Heart J. 131:1996;663-667.
8. Heitzer T., Ylä-Herttuala S., Luoma J. et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation. 93:1996;1346-1353.
9. Huber L.A., Scheffler E., Poll T., Dresel H.A. 17β-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Radic Res Commun. 8:1990;167-173.
10. Mazière C., Auclair M., Ronveaux M-F, Salmon S., Santus R., Mazière J-C Estrogen inhibits copper and cell-mediated modification of low density lipoprotein. Atherosclerosis. 89:1991;175-182.
11. Rifici V.A., Khachadurian A.K. The inhibition of low-density lipoprotein oxidation by 17β-estradiol. Metabolism. 10:1992;1110-1114.
12. Nègre-Salvayre A., Pieraggi M-T, Mabile L., Salvayre R. Protective effect of 17β-estradiol against the cytotoxity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis. 99:1993;207-217.
13. Keaney J.F., Shwaery G.T., Xu A., Nicolosi R.J., Loscalzo J., Foxall T.L., Vita J.A. 17β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 89:1994;2251-2259.
14. Sack M.N., Rader D.J., Cannon R.O. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 343:1994;269-270.
15. Guetta V., Lush R.M., Figg W.D., Waclawiw M.A., Cannon R.O. Effect of the antiestrogen tamoxifen on low-density lipoprotein concentration and oxidation in postmenopausal women. Am J Cardiol. 76:1995;1072-1073.
16. Tuppurainen M., Honkanen R., Kröger H., Saarikoski S., Alhava E. Osteoporosis risk factors, gynecological history and fractures in perimenopausal women-the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas. 17:1993;89-100.
17. Tuppurainen M., Heikkinen A-M, Penttilä I., Saarikoski S. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate & cyproterone acetate and/or vitamin D3. Maturitas. 22:1995;55-61.
18. Heinonen M., Lampi A-M, Hyvönen L., Homer D. The fatty acid and cholesterol content of the average Finnish diet. J Food Comp Anal. 5:1992;198-208.
19. Penttilä I.M., Voutilainen E., Laitinen P., Juutilainen P. Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest. 41:1981;353-360.
20. Friedewald W.T., Levy R.I., Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparation ultracentrifuge. Clin Chem. 18:1972;499-502.
21. Uusitupa M.I.J., Niskanen L., Luoma J. et al. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 16:1996;1236-1242.
22. Kannel W.B., Hjortland M.C., McNamara P.M., Gordon T. Menopause and risk of cardiovascular disease. Ann Intern Med. 85:1976;447-457.
23. Stamper M.J., Colditz G.A. Estrogen replacement therapy and coronary artery disease: A quantitative review of the epidemiologic evidence. Prev Med. 20:1991;47-63.
24. Ylä-Herttuala S., Luoma J., Kallionpää H., Laukkanen M., Lehtolainen P., Viita H. Pathogenesis of atherosclerosis. Maturitas. 23:1996;S47-S49.
25. Wander R.C., Du S-H, Ketchum S.O., Rowe K.E. Effects of interaction of RRR-α-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy. Am J Clin Nutr. 63:1996;184-193.
26. Vaarala O., Alfthan G., Jauhiainen M., Leirisalo-Repo M., Aho K., Palosuo T. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet. 341:1993;923-925.
27. Branch D.W., Mitchell M.D., Miller E., Palinski W., Witztum J.L. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet. 343:1994;645-646.
28. Tulppala M., Ailius K., Palosuo T., Ylikorkala O. Antibodies to oxidized low-density lipoprotein and to cardiolipin in nonpregnant and pregnant women with habitual abortion. Fertil Steril. 64:1995;947-950.